COVID-19: Social distancing, ACE 2 receptors, protease inhibitors and beyond?

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

18 citing papers in PubMed.

1. Communicable disease pandemic: a simulation model based on community transmission and social distancing.Soft computing · 2023
   Article
2. Synergistic anti-SARS-CoV-2 activity of repurposed anti-parasitic drug combinations.BMC pharmacology & toxicology · 2022
   Article
3. A fuzzy rule-based efficient hospital bed management approach for coronavirus disease-19 infected patients.Neural computing & applications · 2022
   Article
4. A novel service robot assignment approach for COVID-19 infected patients: a case of medical data driven decision making.Multimedia tools and applications · 2022
   Article
5. The impact of coronavirus pandemic (COVID-19) on education: The role of virtual and remote laboratories in education.Technology in society · 2021
   Article
6. Reconfiguring and ramping-up ventilator production in the face of COVID-19: Can robots help?Journal of manufacturing systems · 2021
   Article
7. SARS-CoV-2 early infection signature identified potential key infection mechanisms and drug targets.BMC genomics · 2021
   Article
8. Impact of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on the Inflammatory Response and Viral Clearance in COVID-19 Patients.Frontiers in cardiovascular medicine · 2021
   Article
9. Performance analysis of data mining algorithms for diagnosing COVID-19.Journal of education and health promotion · 2021
   Article
10. Pulmonary delivery of nanostructured lipid carriers for effective repurposing of salinomycin as an antiviral agent.Medical hypotheses · 2020
    Article
11. COVID-19: Risk groups, mechanistic insights and challenges.International journal of clinical practice · 2020
    Article
12. COVID-19-associated cardiovascular morbidity in older adults: a position paper from the Italian Society of Cardiovascular Researches.GeroScience · 2020
    Review
13. Plausible mechanisms of Niclosamide as an antiviral agent against COVID-19.Medical hypotheses · 2020
    Article
14. Epidemiology and clinical features of COVID-19: A review of current literature.Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology · 2020
    Review
15. Mutated COVIDNew microbes and new infections · 2020
    Review
16. COVID-19: Rational discovery of the therapeutic potential of Melatonin as a SARS-CoV-2 main Protease Inhibitor.International journal of medical sciences · 2020
    Article
17. Managing Resident Workforce and Education During the COVID-19 Pandemic: Evolving Strategies and Lessons Learned.JB & JS open access
    Review
18. Laparoscopy during the COVID-19 Pandemic: Absence of Evidence is not Evidence of Absence.Journal of Indian Association of Pediatric Surgeons
    Review

Corrections and comments

• Commented on by
  COVID-19: Risk groups, mechanistic insights and challenges.2020
• Comment on
  COVID-19 and rationally layered social distancing.2020

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as